Malignant melanoma is an increasingly common condition in young women. ' pre-existing melanoma is not clear, with conflicting evidence in the literature. Houghton has shown no significant alteration in the prognosis,2 whereas Shiu found a significant worsening due to pregnancy only in Stage 11 disease where regional lymph nodes were involved.3 Eleven studies were reviewed in detail by Holly, who found overall no survival difference related to pregnancy in females with malignant melanoma.4 In fact, Hersey et al demonstrated a better survival in parous women when compared with nulliparous controls.5 Treatment of malignant melanoma remains primarily surgical, which in pregnancy is complicated by the risks of deep vein thrombosis and aspiration pneumonitis if general anaesthesia is used. Hormone manipulation, termination of pregnancy, oophorectomy, adrenalectomy and hypophysectomy have not been shown to be of any benefit. Freedman and MacMahon have shown that metastasis to the placenta and the fetus, fortunately, is rare.6 With regard to future pregnancies, Shiu would discourage pregnancy in patients with a history of Stage II disease or those with previous activation of the lesion during pregnancy.3 Recent reviews of this literature conclude that subsequent pregnancy has little if any adverse effect upon recurrence or survival rates.78 Finally, should these patients use combined oral contraceptives because of the possible adverse effects of any oestrogen components? Early reports were conflicting, and recent case control studies9 have shown no increase in risk with combined oral contraception, suggesting there may be a protective effect in some age groups. There is no advice available on the use of progesterone only contraceptive medication.
